Mani Sharma Appointed to Board

We are pleased to announce the appointment of Mani Sharma to our Board. He will be joining as Non-Executive Director on 1st September 2025 and will also serve as Chair of the Finance and Infrastructure Committee.

Mani brings deep experience in all aspects of finance and business strategy and has held roles based in both the USA and UK with AstraZeneca PLC, Pfizer Inc and GlaxoSmithKline PLC.

He has a strong track record of supporting organisations through challenging situations, including during rapid growth and through financial challenges. He’s also led large-scale change across global teams.

He is enthusiastic about diversity, inclusion, developing people and creating opportunities.

Group Chair Lynda Thomas said: “We’re delighted that Mani is joining on us on the Board. He brings an enormous amount of health experience and finance expertise, which will be hugely helpful in our work to ensure sustainable high-quality services for our patients and our communities.”

Mani is a fellow member of the Association of Chartered Certified Accountants and currently serves as Senior Vice President Finance - Group Controller and Head of Global Finance Services at AstraZeneca PLC, based in Cambridge, UK.